Latest headlines

Tuesday, 30 October, 2007

Generics "too expensive:" Competition Bureau

The federal Competition Bureau is after commissioner Sheridan Scott gave a speech to the CD Howe Institute yesterday about a new study on generic pharmaceuticals that found, in his words, "Competition stops at the pharmacy level and does not accrue to the end payer."

He said legislation like Ontario's Bill 102, which banned kickbacks to pharmacists for stocking brand-name drugs, was a step in the right direction. However, Bill 102 still allows for a limited version of that same kickback system.

Here's a .

Check out our website:


Post a Comment